Estrella Immunopharma (ESLA) traded down -11.8 % during a 24 hours period ending at 07:13 AM Central Europe on Friday 30th. One Estrella Immunopharma stock can currently be bought for about USD 0.73 on popular exchanges. Current supply of Estrella Immunopharma stocks is 43.5 mn. Estrella Immunopharma has a current market capitalization of USD 35.7 mn and approximately USD 407.4 k worth of Estrella Immunopharma was traded on exchanges in the last 24 hours. Since last month end, Estrella Immunopharma has traded 78.7 % up. Simple moving average of last 200 days is at USD 0.99. The highest price of past 52 weeks was recorded at USD 3.15 on 11/04/2025. 52 weeks low was at USD 0.24 on 10/19/2026.
Here is how related stocks have performed in the past 24 hours:
Dogwood Therapeutics (DWTX) traded up 6.9 % and now trades at USD 1.23. Current market capitalisation for Dogwood Therapeutics is USD 42.2 mn.
Sportsman’s Warehouse Holdin (SPWH) traded up 0.47 % and now trades at USD 1.07. Sportsman’s Warehouse Holdin has a market capitalisation of USD 42.3 mn.
Serina Therapeutics (SER) traded down -1.8 % and now trades at USD 1.89. Serina Therapeutics has a market capitalisation of USD 41.7 mn.
Grace Therapeutics (GRCE) traded up 7.49 % and now trades at USD 1.94. Current market capitalisation for Grace Therapeutics is USD 42.3 mn.
Inmune Bio (INMB) traded up 0.66 % and now trades at USD 1.6. Current market capitalisation for Inmune Bio is USD 42.5 mn.
About Estrella Immunopharma
Estrella Immunopharma, Inc. is a preclinical-stage biopharmaceutical company based in Emeryville, United States. The company specializes in developing CD19 and CD22-targeted T-cell therapies to tackle treatment challenges for patients with blood cancers and solid tumors globally.